Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID Subsidiary Partners with U. of Nevada for Radiation Detection Technology

NEW YORK (GenomeWeb News) – PositiveID said today that its subsidiary MicroFluidic Systems is partnering with the University of Nevada to complete development of PositiveID's biodosimetry cartridge for measuring radiation levels.

The platform being developed is a fully integrated system using PositiveID's Dragonfly cartridge, which combines sample collection, preparation and purification, analysis, response, and reporting of results within a multiplexed radiation response biomarker cartridge. The cartridge will contain target specific multiplex assays in an easy-to-use format, the firm said.

MFS is developing a clinical diagnostic countermeasure system as an automated platform for identifying radiation exposure in less than one hour, compared to the two to five days required with current systems and detection technologies, Positive ID said. MFS is partnering with Jeffrey Thompson, dean of the College of Science and a professor of physics at the University of Nevada, to receive irradiated blood samples for development of the biodosimetry cartridge.

The MFS system will be designed for use in limited-resource conditions, small clinics, medical military establishments, and hospitals, it said.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.